Hemagen Diagnostics, Inc.
HMGN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.1K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3,100.00 |
|---|---|
| Enterprise Value | $5.05 Million |
| Earnings per Share | $-0.06 |
| Beta | 0.34 |
| Outstanding Shares | 15,498,962 |
Return
| Return on Equity | 25.51% |
|---|---|
| Return on Assets | -37.14% |
| Return on Invested Capital | -88.86% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.25 |
| Enterprise Value to EBIT | -11.52 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -1.44 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Hemagen Diagnostics, Inc.
15 employees
CEO: William Hales
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of huma...